Navigation Links
ThirdBiotech Announces Kemeta as Newest Sponsor
Date:8/8/2008

PHOENIX, Aug. 8 /PRNewswire/ -- ThirdBiotech Inc., (http://www.thirdbiotech.com), a biotechnology incubator and life sciences association, today announced that Kemeta, a medical device company specializing in the development and manufacture of breath acetone sensing technology and products, has become ThirdBiotech's newest sponsor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO)

"We've successfully established ThirdBiotech as an organization for bringing together the life sciences industry. Now with the establishment of ThirdBiotech Research Group Incubator and Molecular Engineering Research Institute (MERI), we have a core competency center to support and facilitate transformation of researchers and technology into biotech and biodevice companies," said Jeff Morhet, Founder of ThirdBiotech. "We are pleased to have Kemeta join our growing group of sponsors including Arizona Cure, BIO5/University of Arizona, Business Auxiliary Service Corp, Canadian Arizona Business Council, Galbut & Galbut, GE Healthcare, Greater Phoenix Economic Council, InNexus Biotechnology and Osborn Maledon."

The next ThirdBiotech event will be held at 6PM on Thursday, August 21st at La Bocca Pizzeria & Wine Bar located at 7th and Mill Avenue in downtown Tempe, Arizona.

About Kemeta

Kemeta has developed a unique, compact breath analyzer to provide individuals on a weight loss regimen rapid and accurate feedback regarding their fat metabolism using breath acetone as the body's biomarker. The company name, Kemeta, is derived from ketone and metabolism.

Kemeta is a privately held, limited liability company headquartered in Mesa, Arizona. Kemeta has a fully equipped, state-of-the-art R&D laboratory to develop, commercialize and expand Kemeta's products and technology. For more information about
'/>"/>

SOURCE ThirdBiotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
2. ThirdBiotech Networking Group Launches
3. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Anesiva Announces Second Quarter 2008 Financial Results and Update
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
11. Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Involution ... the release of a new infographic, Understanding Ebola ... create a beautifully designed, easy to follow informative tool ... areas of outbreak, symptoms and prevention. , "As the ... that the 2014 Ebola outbreak represents not only a ...
(Date:10/22/2014)... 2014 Grace Century, a private equity ... announces the addition of Dr. Yousef “Josh” Siddiqui ... team. Dr. Siddiqui will provide further healthcare expertise to ... of University College Medical School in the ... in 2001. With further certification as a General Practitioner ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
... LAUSANNE, Switzerland, April 11 Galderma Pharma ... dermatology, today,announced that its U.S. holding company, ... CollaGenex Pharmaceuticals, Inc. (Nasdaq:,CGPI). As a result ... wholly owned,subsidiary of Galderma Laboratories., "We ...
... (http://www.spectodesign.com ), a leading Los Angeles branding and ... renowned biomedical research,institute. (http://www.liai.org ), "This ... the content to the user with,high-impact visuals and user-centric ... for Allergy & Immunology,s dedication to,Finding Cures Faster, in ...
... Inc. (Nasdaq: PPHM ), a clinical stage ... cancer and,hepatitis C virus infection (HCV), today announced ... of oral and poster presentations,at the 2008 Annual ... being held April 12-16, 2008 in San Diego:, ...
Cached Biology Technology:Galderma Completes Acquisition of CollaGenex 2Galderma Completes Acquisition of CollaGenex 3Galderma Completes Acquisition of CollaGenex 4La Jolla Institute for Allergy & Immunology Wows With New Website 2Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting 2
(Date:10/17/2014)... news release is available in German . ... millions of sperms every day in order to reproduce? And ... are the topic of the latest issue of the research ... 2014). The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld ... it is not unusual for a female to copulate with ...
(Date:10/16/2014)... human body. Battles are won, lost or sometimes ... stalemate—known as tumor dormancy—can last up to 25 ... is poorly understood. , A new computational ... a Professor of Chemistry at Princeton University, may ... the switch to a malignant state. Published today ...
(Date:10/16/2014)... the bowel lining develops and, in the process, suggested ... The researchers produced evidence that stem cells are responsible ... feature of the bowel lining, and believe these stem ... finding as scientists are still divided on the stem ... Wee Tan and Professor Tony Burgess from the Walter ...
Breaking Biology News(10 mins):Sperm wars 2Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2
... Scientists now understand how an important protein converts chemical ... cell division, thanks to a new structural model by ... , The structural model helps solve a scientific mystery: ... functions vital to life. These functions include mitosis, or ...
... the first large, single-institution series directly comparing weight-loss ... of Chicago found that a newer operation, the ... the standard operation, the Roux-en-Y gastric bypass. , ... Surgery, the researchers report that the duodenal switch ...
... public alike have been acutely aware of the potential ravages ... might still recall the pandemics of 1968 and 1957, it ... on that scale--that causes the most trepidation. ... died from this particular strain of the flu virus in ...
Cached Biology News:UNC scientists solve mystery of how largest cellular motor protein powers movement 2For super-obese patients, duodenal switch beats gastric bypass 2For super-obese patients, duodenal switch beats gastric bypass 3Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Request Info...
... Mung Bean Nuclease catalyzes the degradation ... yield 5-phosphoryl terminated products. While the nuclease ... very high concentrations the enzyme degrades double-stranded ... Nuclease has been used for transcript mapping ...
Biology Products: